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A B S T R A C T
Previous studies in the Zenica – Doboj Canton, Bosnia and Herzegovina, indicated some different epidemiological
features of Campylobacter infections and high degree of antimicrobial resistance. Therefore, it was important to inves-
tigate epidemiology of Campylobacter jejuni and Campylobacter coli infections by demographic features and anti-
microbial resistance in the 1999–2001 period. A total number of 40 (75.5%) C. jejuni and 13 (24.5%) C. coli non-re-
peated clinical isolates were analyzed. More than half of isolates, 30 (56.6%) were from urban dwellers. Campylobacter
isolates mainly obtained from children under 6 years of age, 42 (79.2%), resulting in far off highest incidence rate of
41.4/100,000/year in this age group. There was noted high degree of resistance to ciprofloxacin in children less than 6
years of age (14.3%), and extremely high overall erythromycin-resistance rate (30%). Campylobacteriosis in this region
is a public health concern not in the term of the number reported cases, but of distinctive epidemiologic features.
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Introduction
Campylobacter jejuni and Campylobacter coli are
still one of the most important enteropathogens in both
industrialized and developing countries with the num-
ber of cases often exceeding those of salmonellosis and
shigellosis1–3. In developing countries, Campylobacter is
the most commonly isolated bacterial pathogen from
children under two years of age with diarrhea, and dis-
ease does not appear to be important in adults3,4. In con-
trast, infection occurs in adults and children in industri-
alized countries5.
Campylobacteriosis is usually self-limited disease.
Antimicrobial therapy was used more common in pa-
tients with C. jejuni than in C. coli diarrhoea6. Ery-
thromycin and fluoroquinolones consider the drugs of
choice for the treatment of Campylobacter infections.
However, recently broad use of these drugs in human
and veterinary medicine has led to the development of
antimicrobial resistance7–12.
Some interesting epidemiological features of Cam-
pylobacter jejuni/coli infections in this region were re-
ported in the previous reports: high carriage rate of C.
coli in both, pre- and post-war periods, by far the high-
est incidence rate of Campylobacter infections in the
children below six years of age in the urban zone and
high ciprofloxacin and erythromycin resistance rates13–15.
This prompted as to follow up the epidemiology of
Campylobacter jejuni and Campylobacter coli causing
diarrhea in this region in the1999–2001 period, distri-
bution among patients by demographic features and an-
tibiotic susceptibility.
Methods
Availability of national surveillance programs in
industrialized countries has facilitated monitoring of
Campylobacter and other gastrointestinal infections5,16.
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National surveillance programs for campylobacteriosis
generally do not exist in the most developing countries,
despite substantial burden of the disease. The estimate
of incidence campylobacter infections in developing co-
untries originates mostly from laboratory-based sur-
veillance3. Campylobacteriosis does not notified disease
in Bosnia and Herzegovina. Gastrointestinal infections
in the Zenica-Doboj Canton are under laboratory-based
surveillance in the Laboratory for Clinical and Sanitary
Microbiology of the Canton Public Health Institution in
Zenica started from 1998. The age, gender, zone of resi-
dence and susceptibility to antimicrobials of all outpa-
tients presenting to the Laboratory with acute diarrhea
were recorded.
The Zenica-Doboj Canton has a total population of
331,229 in two distinct residential zones: an urban zone
where most of the 149,053 inhabitants live in apart-
ments, and farming and agricultural rural zone where
218,758 inhabitants mainly live in farmhouses, rising
domestic animals and working on the land. The Labora-
tory of Clinical and Sanitary Microbiology of the Canton
Public Health Institute in Zenica serves all outpatients
of the Zenica-Doboj Canton. From January 1, 1999 to
December 31, 2001 stool specimens were received from
5,426 consecutive outpatients with diarrhea. There were
2,000 specimens from children up to 6 years of age, 732
from elementary school students, 530 from high school
students, and 1,856 from adults.
The samples were cultured on modified Preston me-
dium (Oxoid, Basingstoke, UK) and incubated in a micro-
-aerophilic atmosphere17,18 at 42°C for 48 hours. Cam-
pylobacter jejuni and Campylobacter coli were identified
using standard microbiological methods19. Forty iso-
lates of C. jejuni and thirteen of C. coli (one isolate from
each patient) were tested by a disc diffusion method us-
ing Mueller-Hinton agar supplemented with 5% sheep
blood and eight antimicrobials (Oxoid): ampicillin (10
µg), erythromycin (15 µg), azithromycin (15 µg) gen-
tamicin (10 µg), tetracycline (30 µg), nalidixic acid (30
µg), ciprofloxacin (5 µg), nitrofurantoin (300 µg). E. coli
(ATCC 25922), and Staphylococcus aureus (ATCC 25923)
control strains were used. For Campylobacter spp. no in-
ternationally accepted criteria for susceptibility testing,
including assessments of breakpoints for susceptible
versus resistant strains are available, so the zones of
growth inhibition were evaluated in accordance with
standards published by the National Committee for
Clinical Laboratory Standards (NCCLS) for aerobic bac-
teria20. The following cutoff values were used: ampicillin
13 mm, erythromycin 13 mm azithromycin 13 mm,
gentamicin 12 mm, tetracycline 14 mm, nalidixic acid
13 mm, ciprofloxacin 15 mm, nitrofurantoin 14 mm.
Results
A total number of 40 (75.5%) C. jejuni and 13 (24.5%)
C. coli strains were isolated in the study period. Twenty-
-five strains were isolated during the year of 1999. 6 in
2000 and 22 in 2001. Corresponding incidence values
were 7.5, 1.8 and 6.6 per 100 000 per year, respectively
(Table 1). More than half of isolates in this period, 30
(56.6%), were from urban dwellers, resulting in the av-
erage incidence rate of 6.7 cases/100,000/year in urban
population, compared with 4.2/100,000/year in rural
one. The most isolations were obtained from children
under 6 years of age, 42 (79.2%), resulting in far off
highest incidence rate of 41.4/100,000/year in this age
group. Corresponding (average) age-specific incidence
values for other age groups were in the range 1.1, to
1.6/100,000/year. In the present study, the age and zone
of residence distributions of the population from whom
specimens were received is not representative of these
distributions in the Zenica-Doboj Canton population as
a whole. Analyzing the percentage of faecal specimens
positive within each age group eliminates sampling
bias; highest rate was again in the youngest age group,
in whom 1.9% of faecal specimens were positive. Isola-
tion rates in other age groups were from 0.2% in the
7–14 age group to 0.8% in the patients over the age 65
years.
Twenty-eight isolates obtained from male (52.8%),
and 25 (47.2%) from female patients, resulting in gen-
der-specific average incidence of 8.3/100 000/year in
male, and 3.8/100,000/year in women, respectively. Ac-
cordingly, the combined male/female ratio for the inci-
dence of campylobacter diarrhea was 2.2:1.
Antimicrobial resistance in Campylobacter jejuni
and Campylobacter coli human isolates has shown in
Figure 1. C. coli strains have shown higher resistance
rates for all antibiotics tested than C. jejuni, except for
gentamycin and nitrofurantoin, for which they were al-
most equal in both species.
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TABLE 1
THE COMPARISION OF CAMPYLOBACTER spp. AND SALMONELLA spp.
GASTROINTESTINAL INFECTIONS IN THE ZENICA-DOBOJ CANTON
Year
(number of samples examined)
Incidence per 100,000/year (number of isolates)
Campylobacter spp. Salmonella spp.21 Total
1998 (1703) 18.3 (78)14 12.7 (55) 40.2 (133)
1999 (1700) 7.5 (25) 16.9 (73) 29.6 (98)
2000 (1862) 1.8 (6) 25.5 (110) 35.0 (116)
2001 (1867) 6.6 (22) NA
NA – data not analyzed (data sources are from laboratory and hospital records)
The highest resistance rates for all antibiotic tested
were noted in the 20–64 age group. The high resistance
rates to nalidixic acid and ciprofloxacin in children un-
der 6 years of age, 27.3% and 14.3%, respectively, have
deserved full attention. The extents of nalidixic acid-
and ciprofloxacin-resistance were higher in the urban
zone, 41.7% and 24.1%, respectively, than in rural zone,
29.4% and 4.3%, respectively. Resistance rates for all
antibiotic tested were much lower in female comparing
to male patients (data not shown).
Discussion
In the 1999–2001 period surprisingly low number of
isolates, and accordingly, significant decrease of cam-
pylobacter infection incidences in this region were re-
corded, comparing to 199814, given that the data source
were from the same laboratory (the same method and
staff). The similar situation was reported for a decrease
in campylobacter carriage rate after the war comparing
the pre-war period in this region13. In the same period,
the number of Salmonella infections increased, so than
the overall incidences of these two microorganisms were
relatively constant during 1998–2000 period21 (Table 1).
Decreasing number of Campylobacter infections was
also observed in some other reports1,22. It might be some
kind of natural counterbalance of these pathogens1. Dif-
ferent reasons were attributed to that: disease preven-
tion efforts1, or changes in nutritional habit of the
population22.
There were two possible explanations for that. The
Institute of Statistics of Federation of Bosnia and Her-
zegovina reported that a 75% to 90% decrease in live-
stock resources was recorded between 1990 and 1998.
(Statistical yearbook of R/F B&H, Sarajevo, 2000) After
the war the meat and poultry for consumption mainly
imported from other countries: importation of poultry
increased from 43% in 1998 to 70% in 1999. Obviously
that the reason for decreasing incidence of Campy-
lobacter infections in this report was not disease preven-
tion efforts (because of restricted available resources af-
ter the war), but rather it was a reflection of its
incidence in food animals from other countries. Besides,
humanitarian aid after the war was stopped, standard
have declined and nutritional habits of the population
have changed: far less milk, meat and product derived
from them consumed during this period. As it was
stated before, some year-to-year variation in incidence
of food borne disease can be attributed to the prevalence
of pathogens in their respective important animal reser-
voirs and the foods derived from them1. The reason for
the variation in incidence of the two pathogens in the
humans might be different epidemiology, origin and
transmission cycle of the two microorganisms. All Cam-
pylobacter infections were sporadic in our region, but
20% of Salmonella infections appeared in small-family
outbreaks21. While epidemiology, natural reservoir and
transmission of the most important Salmonella spp. are
well established23,24, for Campylobacter spp. they are
still poorly understood25. It is because of the complicated
epidemiology of this zoonosis, by sporadic nature of the
disease along with the organism’s wide distribution,
high level of genetic and antigenic diversity, and lack of
representative population samples26. Unfortunately, ep-
idemiological data in this study obtained from only 18
patients (34%). The four of which (22.2%) connected
their illness with particular food items (poultry and beef
meat were involved in the two cases for each), and nine
(50%) of them have had a contact with an animals (five
with pets, three with chicken and one patient with
cows). Therefore, strong epidemiological link between
the cases and potential sources of infection missed.
Although campylobacter isolation rate was low, as in
industrialized countries, both, the highest incidence and
isolation rate of infections in children fewer than 6
years of age are epidemiological features similar to that
of developing countries3. However, irregularities of sam-
pling have influenced the isolation rate. This bias is in-
herent in all laboratory-based surveillance studies, and
reflects actual clinical practice. Most surveys in devel-
oped countries show bimodal age-distribution of infec-
tion2. This unimodal age-specific distribution might be
also consequence of recent war in this region14. Crowded
urban community and poor sanitary conditions influ-
ence spreading of infections to be highest in young
children4,13. Although the youngest are also the most af-
fected population in Salmonella infections in this re-
gion, there was no strictly unimodal age distribution
persisted, but incidence of Salmonella infections rather
have had decreasing trend according to age21.
C. jejuni and C. coli are the two main species isolated
in both, industrialized and developing countries. Isola-
tion rate of C. jejuni usually exceeds that of C. coli7,8. In
this and previous reports from this region, C. coli ac-
counted for 24.5%, 26.5% and 36%13,14. It is surpassingly
given that the post-war population in the Zenica-Doboj
Canton is overwhelmingly Muslim 82.3% (Statistical
yearbook of R/F B&H, Sarajevo, 2000), in which con-
sumption of pork, customarily associated with C. coli in-
fection, is almost nonexistent. It suggests that primary
source of C. coli infection might be something other than
pigs. Such distribution of C. jejuni and C. coli infections
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Fig. 1. Antimicrobial resistance in Campylobacter jejuni and C.
coli human isolates in the 1999–2001 period (antimicrobial ag-
ents: Amp – ampicilin, Azm – azithromycin, Ery – erythromycin,
Gen – gentamycin, Tet – tetracycline, Nal – nalidixic acid, Cip –
ciprofloxacin, Nf – nitrofurantoin)
were shown only in a few reports. In Croatia, excess of
C. coli infections (54%) was probably the consequence of
the local tradition of home slaughter and processing of
pigs at the end of the summer, and the fact that C. coli is
particularly associated with pigs27. In the Central Afri-
can Republic (39%) an individual well-water supply was
identified as a possible source of C. coli infection28.
It was proposed that the single most important route of
Campylobacter infections (50%–70%) in industrialized
countries remains consumption and handling of chick-
en8,22. This should not be surprising in the light of the fre-
quency with which poultry products are consumed and
nearly universal contamination of chicken with Cam-
pylobacter spp.10,22,29. As Campylobacter may be trans-
ferred from animals to humans, the possible development
of antimicrobial resistance in Campylobacter spp., due to
the use of antimicrobial agents in food animals, is a meter
of concern9,12. Studies from northern Europe have associ-
ated fluoroquinolone use in food animals, particularly in
poultry, as the source for human infections with fluo-
roquinolone-resistant Campylobacter spp.12.
It is usual feature of C. coli strains to be more resis-
tant than C. jejuni10,30. High overall erythromycin-resis-
tance rate of Campylobacter spp. isolates (32%) per-
sisted in this region since 1998 (25%)15. In the most
other reports erythromycin resistance is up to 2%7,11. C.
coli strains have usually shown ten times higher resis-
tance rate to erythromycin than C. jejuni7,10. This differ-
ence was much lower in this paper: 46.3% of C. coli iso-
lates were erythromycin-resistant and 26.3% of C. jejuni,
respectively. In the 1998 survey, the erythromycin-resis-
tance in the two species was almost equal15. Such ex-
tremely high erythromycin-resistance rates could be
comparable only with the report from Spain10.
The pig is the favored host of C. coli and historically
been shown to have a high resistance rate to macrolides.
Macrolide tylosin have been permitted as growth pro-
moter in pigs, but not in broilers, and this could explain
the lower proportion of erythromycin-resistant strains
observed in broilers than in the pigs10. Given that C. coli
strains in our region probably to not originate from pigs,
our observation is unexplained. The differences in isola-
tion rate of the different Campylobacter species among
different sources may make it difficult to compare levels
of resistance between the sources. Thus, it is at present
difficult to say whether the higher level of macrolide re-
sistance among C. coli isolates is because of their origin
(most isolates are from pigs) or is related to true differ-
ences among the species30.
The resistance rate to nalidixic acid of 36% is wor-
ried, because the appearance of nalidixic-acid resistance
is the first step to future quinolone resistance10. The
highest rates of fluoroquinolone-resistant Campylobac-
ter spp. have been reported from southern Europe, and
other regions7,10–12,15,31,32. In this study, the frequency of
resistance to ciprofloxacin in the youngest for which
fluoroquinolone use is not recommended was surpass-
ingly high. Thus, overuse of this drug probably did not
the reason for such high frequency of resistance. Some
reports indicated that the source of fluoroquinolne-re-
sistant Campylobacter infections was consuming poul-
try colonized with resistant strains, rather than selec-
tion for Campylobacter resistance in the human gut
after clinical fluoroquinolone use to threat diarrheas11.
In conclusion, existing notification system of infec-
tious diseases in the Zenica – Doboj Canton is not suffi-
cient for the evaluation of campylobacter infections, be-
cause of lacking the most important epidemiological
data for surveillance. So, the problem of campylobac-
teriosis remains underestimated, detection of outbreaks
is not possible and many important epidemiological
data, as a basis for intervention, are not available. The
scale of Campylobacter infections in the community, the
widespread distribution in the environment, and the
paucity of linked microbiological and epidemiological
data mean that, at present, the epidemiology of Campy-
lobacter infections in humans is still poorly understo-
od9,26.
Campylobacteriosis in this region is a public health
concern, but not in the term of the number reported
cases, but of distinctive epidemiological features: signif-
icant proportion of C. coli infections and high erythro-
mycin-resistance rate. Thus, further research is requir-
ed to identify the reservoir of Campylobacter spp. in the
environment.
Preliminary results of epidemiological typing work
about correlation genotypes of fluoroquinolone- and ery-
thromycin-resistant isolates of Campylobacter spp. strains
from humans, poultry and farm-animals are promising
in the efforts to better understanding Campylobacter
epidemiology in this region29,33. The presence of Cam-
pylobacter jejun and C. coli in the water supply in the
Zenica – Doboj Canton also is under investigation. We
hope that they will help us to find sources involved in
contamination and transmission of Campylobacter in-
fections in this region.
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EPIDEMIOLOGIJA CAMPYLOBACTER JEJUNI I CAMPYLOBACTER COLI INFEKCIJA U
ZENI^KO-DOBOJSKOM KANTONU, BOSNA I HERCEGOVINA, U PERIODU 1999.–2001. GODINE
S A @ E T A K
Istra`ivanja infekcija uzrokovanih sa Campylobacter jejuni i Campylobacter coli na podru~ju zeni~ko-dobojskog
kantona u Bosni i Hercegovini sprovedenih do 1998. godine pokazala su neke epidemiolo{ke osobenosti. Zbog toga je
bilo va`no istra`iti epidemiologiju C. jejuni i C. coli infekcija kao i rezistenciju na antibiotike u periodu 1991.–2001.
godine. Ukupno je izolirano 40 (75.5%) C. jejuni i 13 (24.5%) C. coli u ovome periodu. Kod pacijenata iz gradske
sredine je izolirano 30 (56.6%) kamplobaktera. Ve}ina kampilobaktera je izolirana kod djece mla|e od 6 godina sta-
rosti, 42 (79.2%), te je i incidencija u ovoj dobnoj skupini bila daleko najvi{a, 41.4/100,000/godi{nje. U najmla|oj
dobnoj skupini je zabilje`en visok stupanj rezistancije na ciprofloxacin (14.3%) i erythromycin (30%). Uslijed karak-
teristi~ne epidemiolo{ke slike te visoke rezistencije na antibiotike, kampilobakterioza u ovome regionu predstavlja
javno-zdravstveni problem, te su potrebna daljnja istra`ivanja.
